Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

Liver TET1 was found to promote metabolic dysfunction-associated steatotic liver disease (MASLD) by regulating CD36 ...

Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Reports Continued Progress Across Both Obesity and Oncology FranchisesHOUSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its ...

Recent advancements in circulating nucleic acids, including cf-DNA and cf-RNA, have improved diagnostics and monitoring ...

A group of researchers including scientists of the Earth-Life Science Institute (ELSI) at Institute of Science Tokyo have ...

Aura Biosciences, Inc.’s AURA share price has dipped by 15.40%, which has investors questioning if this is right time to buy.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.62, a high estimate of $8.00, ...

Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...

Research lead Sven-Erik Behrens, PhD, at the Institute of Biochemistry and Biotechnology at MLU, and colleagues, reported ...